Common Contracts
2 similar Registration Rights Agreement contracts by Glaxosmithkline PLC, Theravance Biopharma, Inc.
REGISTRATION RIGHTS AGREEMENT AMONG THERAVANCE BIOPHARMA, INC. GLAXOSMITHKLINE PLC GSK FINANCE (NO.3) PLCRegistration Rights Agreement • June 25th, 2020 • Theravance Biopharma, Inc. • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 22, 2020, is by and among THERAVANCE BIOPHARMA, INC., a Cayman Islands exempted company (the “Company”), GLAXOSMITHKLINE PLC, a public limited company incorporated under the laws of England and Wales, with registered number 03888792 (“GSK”), and GSK FINANCE (NO.3) PLC, a public limited company incorporated under the laws of England and Wales, with registered number 12615561 (“GSK Issuer”).
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • June 22nd, 2020 • Glaxosmithkline PLC • Pharmaceutical preparations • New York
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of June 22, 2020, is by and among THERAVANCE BIOPHARMA, INC., a Cayman Islands exempted company (the “Company”), GLAXOSMITHKLINE PLC, a public limited company incorporated under the laws of England and Wales, with registered number 03888792 (“GSK”), and GSK FINANCE (NO.3) PLC, a public limited company incorporated under the laws of England and Wales, with registered number 12615561 (“GSK Issuer”).
